Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Ji

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Medicine in Drug Discovery|April 16, 2020
The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A reviewAlexis Nahama, Roshni Ramachandran, Alvaro Francisco Cisternas, et al.
New Biotechnology|April 12, 2011
Recombinant antibody libraries and selection technologiesHeyue Zhou, Yan-Liang Zhang, Guodi Lu, et al.
Medicine in Drug Discovery|April 15, 2020
Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virusHenry Ji, Ying Yan, Beibei Ding, et al.
ACS Infectious Diseases|August 2, 2021
Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent ModelSteven Blake, Namir Shaabani, Lisa M Eubanks, et al.
Journal of Molecular Cell Biology|July 8, 2022
Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2Runqiang Chen, Hui Xie, Sahba Khorsandzadeh, et al.
Frontiers in Oncology|June 6, 2022
A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune CellsYoug R Thaker, Ianne Rivera, Christophe Pedros, et al.
Cytotherapy|April 13, 2023
Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricideMaria Karvouni, Marcos Vidal-Manrique, Katharina H Susek, et al.
Cancer Research Communications|September 18, 2024
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple MyelomaAaron D Springer, Rengang Wang, Jiawei Wang, et al.
Expert Opinion on Biological Therapy|December 11, 2023
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMETReyna Kv Lim, Matthew Buschman, Alisher Khasanov, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease InhibitorsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Medicine in Drug Discovery|April 16, 2020
The role of afferent pulmonary innervation in ARDS associated with COVID-19 and potential use of resiniferatoxin to improve prognosis: A reviewAlexis Nahama, Roshni Ramachandran, Alvaro Francisco Cisternas, et al.
New Biotechnology|April 12, 2011
Recombinant antibody libraries and selection technologiesHeyue Zhou, Yan-Liang Zhang, Guodi Lu, et al.
Medicine in Drug Discovery|April 15, 2020
Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virusHenry Ji, Ying Yan, Beibei Ding, et al.
ACS Infectious Diseases|August 2, 2021
Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent ModelSteven Blake, Namir Shaabani, Lisa M Eubanks, et al.
Journal of Molecular Cell Biology|July 8, 2022
Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2Runqiang Chen, Hui Xie, Sahba Khorsandzadeh, et al.
Frontiers in Oncology|June 6, 2022
A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune CellsYoug R Thaker, Ianne Rivera, Christophe Pedros, et al.
Cytotherapy|April 13, 2023
Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricideMaria Karvouni, Marcos Vidal-Manrique, Katharina H Susek, et al.
Cancer Research Communications|September 18, 2024
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple MyelomaAaron D Springer, Rengang Wang, Jiawei Wang, et al.
Expert Opinion on Biological Therapy|December 11, 2023
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMETReyna Kv Lim, Matthew Buschman, Alisher Khasanov, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease InhibitorsYuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Pageof 3